Layer 1 blockchain Injective, which focuses on DeFi, raised $40M in a private token sale led by Jump Crypto
- Injective, a layer 1 blockchain focused on decentralized finance uses cases, has raised $40 million in a round led by Jump Crypto. — BH Digital, the crypto division …
Context & Ripple Effects
By August 2022, Jump Crypto had become the default sponsor of trading-oriented crypto infrastructure: within weeks it led Aptos Labs' $150M Series A and backed Hashflow's $25M DeFi trading round, extending a streak that began with its lead in derivatives venue Paradigm's $35M Series A. Injective's $40M private token sale, with BH Digital participating, slots directly into that pattern — a DeFi-specific Layer 1 financed by the market maker whose order flow expertise it most wants.
What makes this round worth revisiting is who wrote the checks and what happened after: the related coverage traces Jump Crypto's rise into a subsequent fall, including reported FTX connections and a pullback from US crypto trading amid regulatory uncertainty — meaning the vertical it seeded now carries its sponsor's risk.
First-order effects
- Injective gains $40M plus Jump Crypto's market-making and trading-systems expertise at the core of its DeFi chain, while BH Digital buys exposure to a trading-native Layer 1 through a private token sale rather than equity.
Second-order effects
- Competing trading-focused chains double down on the same playbook — Sei raises $30M from Jump Crypto and Multicoin ahead of mainnet, and Monad Labs emerges with ex-Jump Trading founders — concentrating talent and capital for trading L1s around a single firm's orbit.
Third-order effects
- If one market maker functions as the de facto central bank of trading-blockchain funding, its reported retreat from US crypto trading under regulatory pressure becomes a structural funding gap for every chain built on its capital and alumni.
The trend: Trading-focused Layer 1 blockchains are consolidating around a single market maker's capital and talent pool, making that sponsor's regulatory fortunes a systemic variable for the whole category.